Tricyclic inhibitors of poly(adp-ribose) polymerases

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 471/06 (2006.01) A61K 31/4375 (2006.01) A61K 31/55 (2006.01) A61K 31/551 (2006.01) A61P 35/00 (2006.01) C07D 209/00 (2006.01) C07D 221/00 (2006.01) C07D 223/00 (2006.01) C07D 243/00 (2006.01) C07D 487/00 (2006.01) C07D 487/06 (2006.01) C07D 519/00 (2006.01)

Patent

CA 2360003

Compounds of formula (I) are poly(ADP-ribosyl)transferase (PARP) inhibitors, and are useful as therapeutics in treatment of cancers and the amelioration of the effects of stroke, head trauma, and neurodegenerative disease. As cancer therapeutics, the compounds of the invention may be used, e.g., in combination with cytotoxic agents and/or radiation.

Cette invention concerne des composés représentés par la formule (I) ci-dessous qui sont des inhibiteurs de la poly(ADP-ribosyl)transferase (PARP) et qui sont utiles pour le traitement des cancers et atténuent les effets d'attaques, de traumatismes crâniens et des maladies neurodégénératives. En tant qu'agents thérapeutiques des cancers, les composés selon l'invention peuvent s'employer notamment en combinaison avec des agents cytotoxiques et/ou des rayons.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Tricyclic inhibitors of poly(adp-ribose) polymerases does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tricyclic inhibitors of poly(adp-ribose) polymerases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tricyclic inhibitors of poly(adp-ribose) polymerases will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1865518

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.